Welcome to our dedicated page for Amkor Technology news (Ticker: $AMKR), a resource for investors and traders seeking the latest updates and insights on Amkor Technology stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Amkor Technology's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Amkor Technology's position in the market.
Amkor Technology, Inc. (Nasdaq: AMKR) reported financial results for Q1 2024, with net sales of $1.37 billion, gross profit of $202 million, operating income of $73 million, net income of $59 million, and earnings per diluted share of $0.24. The company highlighted efforts to expand capacity for AI devices, strengthen partnerships, progress plans for an Advanced packaging and test facility, and focus on production ramp in Vietnam. Quarterly results showed a decrease in net sales compared to Q4 2023, but an increase in gross margin. The company provided guidance for Q2 2024, expecting net sales of $1.40-$1.50 billion, gross margin of 13.0%-15.0%, and net income of $35-$75 million.